News

Pharmabiz8h
Granules reports Q4FY25 revenue from operations at Rs. 1,197.4 crore up by 2% YoY
Granules reports Q4FY25 revenue from operations at Rs. 1,197.4 crore up by 2% YoY: Our Bureau, Bengaluru Wednesday, May 28, 2025, 17:15 Hrs [IST] Granules India Ltd., a vertically ...
Pharmabiz9h
US FDA approves Bio-Thera Solutions & Hikma Pharma’s Starjemza injection, a biosimilar referencing Stelara injection
US FDA approves Bio-Thera Solutions & Hikma Pharma’s Starjemza injection, a biosimilar referencing Stelara injection: Guangzhou Wednesday, May 28, 2025, 17:00 Hrs [IST] Bio-Ther ...
Pharmabiz8h
Phanes Therapeutics begins patient dosing in clinical study of mavrostobart in combination with chemotherapy
Phanes Therapeutics begins patient dosing in clinical study of mavrostobart in combination with chemotherapy: San Diego Wednesday, May 28, 2025, 18:00 Hrs [IST] Phanes Therapeutic ...
Pharmabiz8h
USV’s ‘United for BP Control’ mission targets India’s blood pressure epidemic
USV’s ‘United for BP Control’ mission targets India’s blood pressure epidemic: Our Bureau, Bengaluru Wednesday, May 28, 2025, 17:30 Hrs [IST] USV has launched the ‘Unite ...
Pharmabiz9h
Multi-institutional study highlights role of robotic-assisted surgery in reshaping gynaecological care in India
Multi-institutional study highlights role of robotic-assisted surgery in reshaping gynaecological care in India: Our Bureau, Bengaluru Wednesday, May 28, 2025, 16:15 Hrs [IST] As ...
Pharmabiz10h
Faron Pharma’s bexmarilimab demonstrates immune-activating and drug-sensitizing potential in myeloid malignancies
Faron Pharma’s bexmarilimab demonstrates immune-activating and drug-sensitizing potential in myeloid malignancies: Turku, Finland Wednesday, May 28, 2025, 16:00 Hrs [IST] Faron ...
Pharmabiz12h
Rohini Nilekani Philanthropies, Dalberg Advisors and Ashoka Changemakers present study on ageing and longevity in India
Rohini Nilekani Philanthropies, Dalberg Advisors and Ashoka Changemakers present study on ageing and longevity in India: Our Bureau, Bengaluru Wednesday, May 28, 2025, 13:50 Hrs [ ...
Pharmabiz12h
US FDA places clinical hold on Rocket Pharma's gene therapy phase 2 trial of RP-A501 to treat Danon disease
US FDA places clinical hold on Rocket Pharma's gene therapy phase 2 trial of RP-A501 to treat Danon disease: Cranbury, New Jersey Wednesday, May 28, 2025, 14:00 Hrs [IST] Rocket P ...
Pharmabiz14h
Rein Therapeutics begins patient dosing in in RENEW phase 2 trial of LTI-03 to treat idiopathic pulmonary fibrosis
Rein Therapeutics begins patient dosing in in RENEW phase 2 trial of LTI-03 to treat idiopathic pulmonary fibrosis: Austin, Texas Wednesday, May 28, 2025, 12:00 Hrs [IST] Rein The ...
Pharmabiz12h
Akums Drugs and Pharmaceuticals report PAT of Rs. 147 crore in Q4FY25
Akums Drugs and Pharmaceuticals report PAT of Rs. 147 crore in Q4FY25: Our Bureau, New Delhi Wednesday, May 28, 2025, 13:30 Hrs [IST] Contract development and manufacturing organi ...
Pharmabiz9h
Sir H N Reliance Foundation Hospital launches advanced lung disease clinic to fight pulmonary disorders
Sir H N Reliance Foundation Hospital launches advanced lung disease clinic to fight pulmonary disorders: Our Bureau, Mumbai Wednesday, May 28, 2025, 16:30 Hrs [IST] In a significa ...
Pharmabiz17h
Sanofi completes acquisition of DR-0201, a bispecific myeloid cell engager from Dren Bio
Sanofi completes acquisition of DR-0201, a bispecific myeloid cell engager from Dren Bio: Paris Wednesday, May 28, 2025, 09:00 Hrs [IST] Sanofi announces the completion of its acq ...